Mapping the Heart to Understand Persistent Atrial Fibrillation
Part of Heart & circulation clinical trials.
This study uses a very detailed map of your heart's upper left chamber to find areas causing your persistent atrial fibrillation. The goal is to understand the irregular heartbeat better and help doctors plan more precise treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have persistent atrial fibrillation (a type of irregular heartbeat that lasts for more than a week) that hasn't improved with medication.
- You do not have significant heart valve disease (like moderate to severe mitral valve problems).
- You do not have a blood clot in your heart or a recent heart attack.
- You can attend study follow-up visits and understand what the research involves.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to analyze heart signals in people with long-standing atrial fibrillation that hasn't gotten better with medication. It may help doctors understand your heart rhythm better and guide future treatments.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
This study tests a heart rhythm procedure that uses electrical mapping to guide ablation (controlled scarring) of a specific area in the heart's left upper chamber to treat persistent atrial fibrillation—a condition where the heart beats irregularly for more than a week at a time. The goal is to see if this targeted approach helps restore normal heart rhythm.
This trial tests whether using a special heart-mapping device during ablation (a procedure to fix irregular heartbeats) can improve outcomes for people with persistent atrial fibrillation and an enlarged left heart chamber.
This study tests a new way to treat long-lasting atrial fibrillation using focused energy (pulse field ablation) guided by special heart mapping. It may help people who have not improved with medications or have other heart problems like heart failure.
This trial tests a new way to treat persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days) using a specialized mapping system. It aims to help people who have not gotten relief from medications or cannot tolerate them.
Hear when a new Atrial Fibrillation Recurrent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.